These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17161778)

  • 1. TASC II document on the management of peripheral arterial disease.
    Adam DJ; Bradbury AW
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):1-2. PubMed ID: 17161778
    [No Abstract]   [Full Text] [Related]  

  • 2. [New international consensus document on peripheral arterial disease. TASC II for improved care].
    Norgren L
    Lakartidningen; 2007 May 9-15; 104(19):1474-5. PubMed ID: 17550020
    [No Abstract]   [Full Text] [Related]  

  • 3. The TASC supplement - international recommendations for management of peripheral arterial disease.
    Schroeder TV
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):563. PubMed ID: 10873720
    [No Abstract]   [Full Text] [Related]  

  • 4. Why TASC II?
    Norgren L; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):327. PubMed ID: 18048470
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification.
    White JV; Ryjewski C
    Semin Vasc Surg; 2007 Mar; 20(1):54-61. PubMed ID: 17386364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies: Transatlantic Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).
    Ricco JB; Parvin S; Veller M; Brunkwall J; Wolfe J; Sillesen H; Eckstein HH; Fitridge R
    Eur J Vasc Endovasc Surg; 2014 Feb; 47(2):118. PubMed ID: 26113131
    [No Abstract]   [Full Text] [Related]  

  • 7. TASC II: a focus on opportunities.
    Stansby G
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):753. PubMed ID: 18374610
    [No Abstract]   [Full Text] [Related]  

  • 8. Reporting guidelines for open and endovascular surgery: why the current recommendations should be revised.
    Myers KA
    J Endovasc Surg; 1995 Nov; 2(4):321-8. PubMed ID: 9234148
    [No Abstract]   [Full Text] [Related]  

  • 9. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    Norgren L; Hiatt WR; Dormandy JA; Nehler MR; Harris KA; Fowkes FG; ; Bell K; Caporusso J; Durand-Zaleski I; Komori K; Lammer J; Liapis C; Novo S; Razavi M; Robbs J; Schaper N; Shigematsu H; Sapoval M; White C; White J; Clement D; Creager M; Jaff M; Mohler E; Rutherford RB; Sheehan P; Sillesen H; Rosenfield K
    Eur J Vasc Endovasc Surg; 2007; 33 Suppl 1():S1-75. PubMed ID: 17140820
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines on the management of peripheral arterial disease.
    Hainsworth T
    Nurs Times; 2006 Oct 31-Nov 6; 102(44):23-4. PubMed ID: 17112150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femoral stenting: what do the guidelines tell us.
    Minar E
    J Cardiovasc Surg (Torino); 2013 Apr; 54(2):211-5. PubMed ID: 23558656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).
    Norgren L; Hiatt WR; Jaff MR
    Eur J Vasc Endovasc Surg; 2014 May; 47(5):461. PubMed ID: 24851281
    [No Abstract]   [Full Text] [Related]  

  • 15. [Do patients with vascular diseases receive sufficiently good care?].
    Lindahl AK
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2341. PubMed ID: 19935932
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing practice of general practitioners in Northern Ireland for peripheral arterial disease.
    Badger SA; Soong CV; Lee B; Swain GR; McGuigan KE
    Angiology; 2008; 59(1):57-63. PubMed ID: 18319223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midwestern Vascular Surgical Society: new horizons in vascular surgery program.
    Reed AB
    Perspect Vasc Surg Endovasc Ther; 2009 Dec; 21(4):213. PubMed ID: 20628093
    [No Abstract]   [Full Text] [Related]  

  • 18. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
    Ansel GM; Jaff MR
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical management of peripheral arterial disease.
    Paraskevas KI; Hamilton G; Mikhailidis DP; Liapis CD
    Vasc Endovascular Surg; 2007; 41(1):87. PubMed ID: 17277251
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral arterial disease practice guidelines and sausage.
    Sacks D; Haskal ZJ
    J Vasc Interv Radiol; 2006 Sep; 17(9):1379-81. PubMed ID: 16990458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.